Pfizer strikes deal with Trump to discount drug prices
Pfizer reached an agreement with Trump to generally cut drug prices in the United States, offer steep discounts, sell drugs at most-favored-nation prices, and increase investment in research and development and local manufacturing. Trump gave Pfizer a three-year grace period.